{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "AVEO",
        "Security_Name": "AVEO Pharmaceuticals, Inc. - Common Stock",
        "Listing_Exchange": "Q",
        "Market_Category": "S",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "N",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "AVEO",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 0,
                "buy": 3,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 3,
                "buy": 2,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 3,
                "buy": 2,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 2,
        "previousClose": 14.96,
        "open": 14.95,
        "dayLow": 14.93,
        "dayHigh": 14.95,
        "regularMarketPreviousClose": 14.96,
        "regularMarketOpen": 14.95,
        "regularMarketDayLow": 14.93,
        "regularMarketDayHigh": 14.95,
        "payoutRatio": 0,
        "beta": 0.710759,
        "forwardPE": -87.82353,
        "volume": 799209,
        "regularMarketVolume": 799209,
        "averageVolume": 1263667,
        "averageVolume10days": 512300,
        "averageDailyVolume10Day": 512300,
        "bid": 14.93,
        "ask": 14.94,
        "bidSize": 1200,
        "askSize": 21500,
        "marketCap": 513203840,
        "fiftyTwoWeekLow": 3.06,
        "fiftyTwoWeekHigh": 14.98,
        "priceToSalesTrailing12Months": 6.4927173,
        "fiftyDayAverage": 14.87,
        "twoHundredDayAverage": 8.82165,
        "currency": "USD",
        "fromCurrency": null,
        "lastMarket": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "3Q2021",
                    "actual": -0.3,
                    "estimate": -0.36
                },
                {
                    "date": "4Q2021",
                    "actual": -0.21,
                    "estimate": -0.29
                },
                {
                    "date": "1Q2022",
                    "actual": -0.3,
                    "estimate": -0.25
                },
                {
                    "date": "2Q2022",
                    "actual": -0.24,
                    "estimate": -0.28
                }
            ],
            "currentQuarterEstimate": -0.18,
            "currentQuarterEstimateDate": "3Q",
            "currentQuarterEstimateYear": 2022,
            "earningsDate": [
                1678665600,
                1679011200
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 5409000,
                    "earnings": -5329000
                },
                {
                    "date": 2019,
                    "revenue": 28795000,
                    "earnings": 9388000
                },
                {
                    "date": 2020,
                    "revenue": 6019000,
                    "earnings": -35584000
                },
                {
                    "date": 2021,
                    "revenue": 42295000,
                    "earnings": -53342000
                }
            ],
            "quarterly": [
                {
                    "date": "3Q2021",
                    "revenue": 15173000,
                    "earnings": -10368000
                },
                {
                    "date": "4Q2021",
                    "revenue": 17646000,
                    "earnings": -7255000
                },
                {
                    "date": "1Q2022",
                    "revenue": 20920000,
                    "earnings": -10199000
                },
                {
                    "date": "2Q2022",
                    "revenue": 25304000,
                    "earnings": -8319000
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1678665600,
                1679011200
            ],
            "earningsAverage": -0.18,
            "earningsLow": -0.2,
            "earningsHigh": -0.15,
            "revenueAverage": 29550000,
            "revenueLow": 28300000,
            "revenueHigh": 30080000
        },
        "dividendDate": "2020-02-20T00:00:00.000Z"
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-10-24T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Market Perform",
                "fromGrade": "Outperform",
                "action": "down"
            },
            {
                "epochGradeDate": "2022-10-19T00:00:00.000Z",
                "firm": "Baird",
                "toGrade": "Neutral",
                "fromGrade": "Outperform",
                "action": "down"
            },
            {
                "epochGradeDate": "2022-10-18T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Neutral",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2021-07-12T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-03-11T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-01-19T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2020-08-13T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-05-01T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "reit"
            },
            {
                "epochGradeDate": "2020-04-01T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "reit"
            },
            {
                "epochGradeDate": "2020-04-01T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "reit"
            },
            {
                "epochGradeDate": "2020-03-18T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2019-09-11T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "Neutral",
                "action": "up"
            },
            {
                "epochGradeDate": "2019-02-04T00:00:00.000Z",
                "firm": "B. Riley Securities",
                "toGrade": "Neutral",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2019-02-01T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Neutral",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2019-01-04T00:00:00.000Z",
                "firm": "Baird",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-08-16T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2017-10-06T00:00:00.000Z",
                "firm": "Seaport Global",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2016-05-19T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2016-03-30T00:00:00.000Z",
                "firm": "FBR Capital",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2015-03-09T00:00:00.000Z",
                "firm": "RBC Capital",
                "toGrade": "Sector Perform",
                "fromGrade": "Underperform",
                "action": "up"
            },
            {
                "epochGradeDate": "2013-12-16T00:00:00.000Z",
                "firm": "RBC Capital",
                "toGrade": "Underperform",
                "fromGrade": "Sector Perform",
                "action": "down"
            },
            {
                "epochGradeDate": "2013-05-03T00:00:00.000Z",
                "firm": "RBC Capital",
                "toGrade": "Sector Perform",
                "fromGrade": "Outperform",
                "action": "down"
            },
            {
                "epochGradeDate": "2013-05-03T00:00:00.000Z",
                "firm": "Stifel",
                "toGrade": "Hold",
                "fromGrade": "Sell",
                "action": "up"
            },
            {
                "epochGradeDate": "2013-05-03T00:00:00.000Z",
                "firm": "Canaccord Genuity",
                "toGrade": "Hold",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2013-05-02T00:00:00.000Z",
                "firm": "William Blair",
                "toGrade": "Market Perform",
                "fromGrade": "Outperform",
                "action": "down"
            },
            {
                "epochGradeDate": "2013-05-02T00:00:00.000Z",
                "firm": "JP Morgan",
                "toGrade": "Neutral",
                "fromGrade": "Overweight",
                "action": "down"
            },
            {
                "epochGradeDate": "2013-05-02T00:00:00.000Z",
                "firm": "BMO Capital",
                "toGrade": "Underperform",
                "fromGrade": "Market Perform",
                "action": "down"
            },
            {
                "epochGradeDate": "2013-04-02T00:00:00.000Z",
                "firm": "JMP Securities",
                "toGrade": "Market Perform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2013-02-14T00:00:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Hold",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2012-11-14T00:00:00.000Z",
                "firm": "Stifel",
                "toGrade": "Sell",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2012-10-31T00:00:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Hold",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2012-08-03T00:00:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Hold",
                "fromGrade": "Buy",
                "action": "down"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "DELAYED",
        "postMarketChangePercent": 0,
        "postMarketChange": 0,
        "postMarketTime": "2023-01-06T22:56:33.000Z",
        "postMarketPrice": 14.93,
        "postMarketSource": "DELAYED",
        "regularMarketChangePercent": -0.0020053298,
        "regularMarketChange": -0.029999733,
        "regularMarketTime": "2023-01-06T21:00:04.000Z",
        "priceHint": 2,
        "regularMarketPrice": 14.93,
        "regularMarketDayHigh": 14.95,
        "regularMarketDayLow": 14.93,
        "regularMarketVolume": 799209,
        "averageDailyVolume10Day": 512300,
        "averageDailyVolume3Month": 1263667,
        "regularMarketPreviousClose": 14.96,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 14.95,
        "exchange": "NCM",
        "exchangeName": "NasdaqCM",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "AVEO",
        "underlyingSymbol": null,
        "shortName": "AVEO Pharmaceuticals, Inc.",
        "longName": "AVEO Pharmaceuticals, Inc.",
        "currency": "USD",
        "quoteSourceName": "Delayed Quote",
        "currencySymbol": "$",
        "fromCurrency": null,
        "lastMarket": null,
        "marketCap": 513203840
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 2,
        "enterpriseValue": 472526976,
        "forwardPE": 41.47222,
        "profitMargins": -0.45723,
        "floatShares": 34476519,
        "sharesOutstanding": 34374000,
        "sharesShort": 1140396,
        "sharesShortPriorMonth": 948907,
        "sharesShortPreviousMonthDate": 1663200000,
        "dateShortInterest": 1665705600,
        "sharesPercentSharesOut": 0.032899998,
        "heldPercentInsiders": 0.0018799999,
        "heldPercentInstitutions": 0.28282,
        "shortRatio": 2.96,
        "shortPercentOfFloat": 0.0372,
        "beta": 0.710759,
        "category": null,
        "bookValue": 1.313,
        "priceToBook": 11.370907,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-06-30T00:00:00.000Z",
        "netIncomeToCommon": -36141000,
        "trailingEps": -1.663,
        "forwardEps": -0.17,
        "lastSplitFactor": "1:10",
        "lastSplitDate": "2020-02-20T00:00:00.000Z",
        "enterpriseToRevenue": 5.978,
        "enterpriseToEbitda": -15.014
    },
    "summaryProfile": {
        "address1": "30 Winter Street",
        "city": "Boston",
        "state": "MA",
        "zip": "02108",
        "country": "United States",
        "phone": "857 400 0101",
        "fax": "617 995 4995",
        "website": "https://www.aveooncology.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "AVEO Pharmaceuticals, Inc., an oncology-focused biopharmaceutical company, focuses on developing and commercializing medicines for patients with cancer. It markets FOTIVDA, an oral, next-generation vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC). The company is also developing tivozanib for the treatment of RCC, hepatocellular carcinoma, ovarian cancer, immunologically cold tumors, and cholangiocarcinoma. In addition, it is developing Ficlatuzumab, a potent humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor that is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma, pancreatic cancer, and acute myeloid leukemia; AV-380, a potent humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia; AV-203, a potent humanized IgG1 monoclonal antibody that targets ErbB3; and AV-353 that targets the Notch 3 pathway. The company has collaborations and license agreements with AstraZeneca PLC; EUSA Pharma (UK) Limited; Biodesix, Inc.; CANbridge Life Sciences, Ltd.; Biogen Idec International GmbH; St. Vincent's Hospital Sydney Limited; and Kyowa Kirin Co., Ltd. The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Boston, Massachusetts.",
        "fullTimeEmployees": 114,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 14.93,
        "targetHighPrice": 15,
        "targetLowPrice": 15,
        "targetMeanPrice": 15,
        "targetMedianPrice": 15,
        "recommendationMean": 2.4,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 5,
        "totalCash": 77160000,
        "totalCashPerShare": 2.229,
        "ebitda": -31472000,
        "totalDebt": 38434000,
        "quickRatio": 2.962,
        "currentRatio": 3.098,
        "totalRevenue": 79043000,
        "debtToEquity": 125.655,
        "revenuePerShare": 2.295,
        "returnOnAssets": -0.18676001,
        "returnOnEquity": -0.79613996,
        "grossProfits": 11260000,
        "freeCashflow": -19485250,
        "operatingCashflow": -30927000,
        "revenueGrowth": 2.349,
        "grossMargins": 0.54994,
        "ebitdaMargins": -0.39816,
        "operatingMargins": -0.39902002,
        "profitMargins": -0.45723,
        "financialCurrency": "USD"
    }
}